company background image
300972 logo

Fujian Wanchen Biotechnology Group SZSE:300972 Stock Report

Last Price

CN¥63.89

Market Cap

CN¥11.5b

7D

-1.4%

1Y

89.7%

Updated

23 Nov, 2024

Data

Company Financials +

Fujian Wanchen Biotechnology Group Co., Ltd.

SZSE:300972 Stock Report

Market Cap: CN¥11.5b

300972 Stock Overview

Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. More details

300972 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth6/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Fujian Wanchen Biotechnology Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fujian Wanchen Biotechnology Group
Historical stock prices
Current Share PriceCN¥63.89
52 Week HighCN¥80.00
52 Week LowCN¥17.69
Beta-0.037
11 Month Change6.45%
3 Month Change130.32%
1 Year Change89.70%
33 Year Change310.87%
5 Year Changen/a
Change since IPO134.03%

Recent News & Updates

Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Nov 04
Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Oct 01
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

Sep 30
Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

Recent updates

Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Nov 04
Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Oct 01
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

Sep 30
Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt

Aug 04
We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt

Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)

Jun 06
Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)

Shareholder Returns

300972CN FoodCN Market
7D-1.4%-3.5%-2.1%
1Y89.7%-6.7%2.8%

Return vs Industry: 300972 exceeded the CN Food industry which returned -6.7% over the past year.

Return vs Market: 300972 exceeded the CN Market which returned 2.8% over the past year.

Price Volatility

Is 300972's price volatile compared to industry and market?
300972 volatility
300972 Average Weekly Movement13.3%
Food Industry Average Movement6.9%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 300972's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300972's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20114,972Li Qing Wangwww.vanchen.com

Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.

Fujian Wanchen Biotechnology Group Co., Ltd. Fundamentals Summary

How do Fujian Wanchen Biotechnology Group's earnings and revenue compare to its market cap?
300972 fundamental statistics
Market capCN¥11.50b
Earnings (TTM)CN¥57.69m
Revenue (TTM)CN¥25.01b

199.3x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300972 income statement (TTM)
RevenueCN¥25.01b
Cost of RevenueCN¥22.41b
Gross ProfitCN¥2.60b
Other ExpensesCN¥2.54b
EarningsCN¥57.69m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.32
Gross Margin10.38%
Net Profit Margin0.23%
Debt/Equity Ratio105.2%

How did 300972 perform over the long term?

See historical performance and comparison